FIGURE 4-2. The Therapeutics Development Network of cystic fibrosis clinical care centers.

FIGURE 4-2The Therapeutics Development Network of cystic fibrosis clinical care centers

Principal investigators and staff have experience in the design and conduct of clinical trials for cystic fibrosis and access to patients for trial enrollment.

NOTE: CF = cystic fibrosis; CFFT = Cystic Fibrosis Foundation Therapeutics, Inc.; HRCT = high-resolution computed tomography; IPFT = infant pulmonary function testing; NPD = nasal potential difference test.

SOURCE: Wetmore, 2008.

From: 4, Diverse Funding Models

Cover of Breakthrough Business Models
Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary.
Institute of Medicine (US) Forum on Drug Discovery, Development, and Translation.
Washington (DC): National Academies Press (US); 2009.
Copyright © 2009, National Academy of Sciences.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.